Chinese healthcare stocks hit by stepped up anti-graft crackdown
SHANGHAI (Reuters) – A year-long slump in China’s healthcare stocks has accelerated this week as an anti-corruption campaign gathers pace, threatening the sales of some drug makers and medical equipment…